<DOC>
	<DOCNO>NCT01479556</DOCNO>
	<brief_summary>This study phase IV clinical trial objective evaluate whether pain relief associate pregabalin at-level non-evoked evoked neuropathic pain efficient early rather late subacute phase spinal cord injury .</brief_summary>
	<brief_title>Pregabalin Treatment Prevention Spinal Cord Injury Neuropathic Pain</brief_title>
	<detailed_description />
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Spinal Cord Injuries</mesh_term>
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Comprehension clinical trial sign informed consent initiation . Male female adult , age 18 70 . Clinical history neuropathic pain secondary SCI Patients AIS A , B , C D accord American Spinal Cord Injury Association ( ASIA ) Impairment Scale . Persistent neuropathic pain 1 month 6 month spinal cord injury . Nonevoked atlevel pain ≥ 2 intensity measure numerical rating scale ( 010 ) . Nonevoked/evoked atlevel pain correspond area sensory alteration , within three dermatome neurological level spinal cord injury . Formal acceptance disponibility program clinical trial visit protocol requisite . Females child bear age must demonstrate negative pregnancy test ( perform screen subsequent follow visit ) use reliable birth control method include abstinence sexual activity throughout duration study last 28 day termination clinical trial . Previous actual use gabapentin . Creatinine clearance level &lt; 60 ml/min . Neuropathic pain unrelated spinal cord injury . Lactose intolerance , Lapp lactase insufficiency glucose malabsorption Platelet count &lt; 100x103/µl . White blood cell count &lt; 2.5 x103/µl . Neutrophil count &lt; 1.5 x103/µl . Planned surgery clinical trial . Patients peripheral neuropathic pain . Previous history malignant melanoma . History malignant tumor , except situ uterine cervix carcinoma , situ basocellular spinocellular cutaneous carcinoma , superficial bladder tumor ( Ta Tis ) complete treatment response 10 year . Patients history lymphoma breast cancer allow participate trial complete treatment response observe 20 year . Chronic active infection require systemic therapy , chronic kidney infection , chronic lung infection bronchiectasias , Mycobacterium tuberculosis infection , active Hepatitis B C. Diagnosis latent TB confection perform accord local guideline . Severe heart diseases unstable angina , cardiopathy first 6 month myocardial infarction , grade III IV New York Heart Association scale congestive heart failure . Unknown kidney , liver , gastrointestinal , endocrine , lung , hematological , neurological psychiatric comorbidities . Subjects administer experimental noncommercial drug 4 week prior trial . Patients participate clinical study . Patients competent complete require task ( eg . alcohol drug relate problem psychiatric disorder ) . Subjects unable examined radiological MRI exploration due contraindication . Pregnancy breastfeed . Any patient condition deem unsuitable subject inclusion trial accord research team .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Pregabalin</keyword>
	<keyword>Neuropathic pain</keyword>
	<keyword>At-level neuropathic pain</keyword>
	<keyword>Non-evoked neuropathic pain</keyword>
	<keyword>Evoked neuropathic pain</keyword>
	<keyword>Sub-acute spinal cord injury</keyword>
</DOC>